Metabolomics is the study of metabolites, small molecules which have a unique chemical fingerprint when analysed closely. By investigating metabolites and how they influence cellular processes, we are able to learn more about what makes people healthy or ill.
Research at INFANT, in collaboration with its industry partners, aims to address unmet technical needs in the field with innovative technology and instrumentation. Our recent advances in metabolomics, microRNA technologies and bioinformatics are essential to developing early pregnancy screening tests. These tests will present an effective method of predicting diseases and have the potential to dramatically improve maternal and infant health worldwide.